Phathom Pharmaceuticals, Inc.
NASDAQPhathom Pharmaceuticals heads into mid-June with short sellers holding their most aggressive stance in months — and the borrow market beginning to catch up. Short interest is the headline story here. Bears have built their position to 14.8% of the free float, up 7.6% over the past month and nudging higher again this week. That's a meaningful accumulation by any measure, and the…
Snapshot as of 18 Jun 2026
Phathom Pharmaceuticals heads into mid-June with short sellers holding their most aggressive stance in months — and the borrow market beginning to catch up. Short interest is the headline story here. Bears have built…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PHAT — free to start on ORTEX.
Sign up for free →Open PHAT on ORTEX